Clinical Trial Update: Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial update for Lyrica in Restless Legs Syndrome has been completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-02-04